Plyometric-Based Hydro-Kinesio Therapy in Children With Hemophilic Arthropathy
How Effective is the Plyometric-based Hydro-kinesio Therapy for Pain, Muscle Strength, Postural Control, and Functional Performance in Children With Hemophilic Knee Arthropathy?
1 other identifier
interventional
48
1 country
1
Brief Summary
This study was designed to assess the effect of an 8-week plyometric-based hydro-kinesio therapy (Plyo-HKT) on pain, muscle strength, postural control, and functional performance in a convenience sample of children with hemophilic knee arthropathy (HKA). Forty-eight patients with HKA were randomly allocated to the Plyo-HKT group (n = 24, received the plyometric-based hydro-kinesio therapy program, twice/week, over 8 weeks) or the control group (n = 24, received standard exercise program). Both groups were assessed for pain, muscle strength, postural control, and functional performance pre and post-treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 26, 2023
CompletedFirst Submitted
Initial submission to the registry
July 7, 2023
CompletedFirst Posted
Study publicly available on registry
July 17, 2023
CompletedJuly 17, 2023
July 1, 2023
1.4 years
July 7, 2023
July 7, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Pain intensity
Participants reported how much they feel pain during rest and/or movement on the 0-10 Numerical Pain Rating Scale, where 0 represents "no pain" and 10 indicates the "worst possible pain".
2 months
Muscle strength
Indicated by the peak concentric torque of the quadriceps and hamstring muscles (Nm). It was measured using an Isokinetic Dynamometer.
2 months
Postural control
The capacity to control and move the center of gravity in various directions across the base of support was assessed utilizing the Biodex balance system. Values are expressed as accuracy % and higher scores mean better balance capability.
2 months
Secondary Outcomes (2)
Functional independence
2 months
Six-minute walk test
2 months
Study Arms (2)
Plyo-HKT group
EXPERIMENTALParticipants in this group received the Plyo-HKT program
Control group
ACTIVE COMPARATORParticipants in this group received the standard exercise program.
Interventions
The plyometric-based hydro-kinesio therapy was conducted for 45 minutes, twice weekly, for 8 successive weeks. The training was geared toward the lower body and was conducted under the close supervision of a licensed pediatric physical therapist in accordance with the safety performance guidelines defined by the American Academy of Pediatrics and the US National Strength and Conditioning Association.
The program encompassed the standard exercises for patients with JIA (aerobic, weight-bearing, proprioceptive, flexibility, and strengthening exercises). The training was conducted for 45 minutes, two times a week for 8 successive weeks.
Eligibility Criteria
You may qualify if:
- Eight and 16 years.
- Had factor VIII replacement prophylaxis.
- Clinically-stable.
- Unilateral knee involvement.
- Knee arthropathy of grade II or III per the Arnold-Hilgartner radiographic classification.
- Muscle strength of grade 3 in lower limb muscles.
- Use of no pain medication for one month prior to enrollment.
- Walking independently.
You may not qualify if:
- Enduring disabling pain
- Fixed deformities.
- History of musculoskeletal surgery.
- Visual or vestibular deficits.
- Engagement in regular exercises.
- Bleeding episodes within two weeks prior to enrolment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Ragab K. Elnaggar
Al Kharj, Riyadh Region, Saudi Arabia
Study Officials
- PRINCIPAL INVESTIGATOR
Ragab K Elnaggar, PhD
Prince Sattam Bin Abdulaziz University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- This was a single-blind protocol. The researcher who collected the data was blinded to the treatment allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 7, 2023
First Posted
July 17, 2023
Study Start
September 5, 2021
Primary Completion
January 26, 2023
Study Completion
January 26, 2023
Last Updated
July 17, 2023
Record last verified: 2023-07